KR102885025B1 - 유전적 조절 - Google Patents

유전적 조절

Info

Publication number
KR102885025B1
KR102885025B1 KR1020207012736A KR20207012736A KR102885025B1 KR 102885025 B1 KR102885025 B1 KR 102885025B1 KR 1020207012736 A KR1020207012736 A KR 1020207012736A KR 20207012736 A KR20207012736 A KR 20207012736A KR 102885025 B1 KR102885025 B1 KR 102885025B1
Authority
KR
South Korea
Prior art keywords
dna
homo sapiens
chromosomal
interactions
nucleic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020207012736A
Other languages
English (en)
Korean (ko)
Other versions
KR20200081380A (ko
Inventor
알렉상드르 아쿨리츠체프
어로울 셀밤 라마다스
이완 헌터
Original Assignee
옥스포드 바이오다이나믹스 피엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 옥스포드 바이오다이나믹스 피엘씨 filed Critical 옥스포드 바이오다이나믹스 피엘씨
Publication of KR20200081380A publication Critical patent/KR20200081380A/ko
Application granted granted Critical
Publication of KR102885025B1 publication Critical patent/KR102885025B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020207012736A 2017-11-03 2018-11-02 유전적 조절 Active KR102885025B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762581287P 2017-11-03 2017-11-03
US62/581,287 2017-11-03
GBPCT/GB2018/052818 2018-10-03
GB2018052818 2018-10-03
PCT/GB2018/053196 WO2019086898A2 (en) 2017-11-03 2018-11-02 Genetic regulation

Publications (2)

Publication Number Publication Date
KR20200081380A KR20200081380A (ko) 2020-07-07
KR102885025B1 true KR102885025B1 (ko) 2025-11-11

Family

ID=64661410

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207012736A Active KR102885025B1 (ko) 2017-11-03 2018-11-02 유전적 조절

Country Status (13)

Country Link
US (1) US11840737B2 (cg-RX-API-DMAC7.html)
EP (1) EP3704274B1 (cg-RX-API-DMAC7.html)
JP (2) JP2021501592A (cg-RX-API-DMAC7.html)
KR (1) KR102885025B1 (cg-RX-API-DMAC7.html)
CN (1) CN111511930B (cg-RX-API-DMAC7.html)
AU (1) AU2018361833B2 (cg-RX-API-DMAC7.html)
CA (1) CA3078675A1 (cg-RX-API-DMAC7.html)
ES (1) ES2987603T3 (cg-RX-API-DMAC7.html)
HU (1) HUE066292T2 (cg-RX-API-DMAC7.html)
MY (1) MY199800A (cg-RX-API-DMAC7.html)
PL (1) PL3704274T3 (cg-RX-API-DMAC7.html)
SG (1) SG11202003233YA (cg-RX-API-DMAC7.html)
WO (1) WO2019086898A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3152645A1 (en) * 2019-09-11 2021-03-18 Oxford BioDynamics PLC Diagnostic chromosome marker
IL296568A (en) * 2020-03-17 2022-11-01 Regeneron Pharma Methods and systems for determining responders to treatment
GB202008269D0 (en) * 2020-06-02 2020-07-15 Oxford Biodynamics Ltd Detecting a chromosome marker
GB202016176D0 (en) * 2020-10-12 2020-11-25 Oxford BioDynamics PLC Disease marker
TW202302862A (zh) * 2021-03-04 2023-01-16 英商牛津生物力學公眾有限公司 染色體交互作用標記物
WO2025215189A1 (en) * 2024-04-12 2025-10-16 Oxford BioDynamics PLC Chromosome marker test

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016207653A1 (en) 2015-06-24 2016-12-29 Oxford Biodynamics Limited Detection of chromosome interactions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR036993A1 (es) * 2001-04-02 2004-10-20 Wyeth Corp Uso de agentes que modulan la interaccion entre pd-1 y sus ligandos en la submodulacion de respuestas inmunologicas
GB0603251D0 (en) 2006-02-17 2006-03-29 Isis Innovation DNA conformation
CN101688237A (zh) 2007-01-11 2010-03-31 伊拉兹马斯大学医疗中心 环状染色体构象捕获(4c)
EP2201140A2 (en) 2007-10-15 2010-06-30 Takeda Pharmaceutical Company Limited Preventive/remedy for cancer
GB0810051D0 (en) 2008-06-02 2008-07-09 Oxford Biodynamics Ltd Method of diagnosis
CN102549167B (zh) 2009-05-12 2017-04-26 皇家飞利浦电子股份有限公司 作为前列腺癌标志物的磷酸二酯酶4d7
AU2014275166B2 (en) * 2013-06-06 2020-09-10 Dana-Farber Cancer Institute, Inc. Compositions and methods for identification, assessment prevention, and treatment of cancer using PD-L1 isoforms
WO2015077414A1 (en) 2013-11-20 2015-05-28 Dana-Farber Cancer Institute, Inc. Kynurenine pathway biomarkers predictive of anti-immune checkpoint inhibitor response

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016207653A1 (en) 2015-06-24 2016-12-29 Oxford Biodynamics Limited Detection of chromosome interactions
WO2016207661A1 (en) 2015-06-24 2016-12-29 Oxford Biodynamics Limited Detection processes using sites of chromosome interaction

Also Published As

Publication number Publication date
WO2019086898A2 (en) 2019-05-09
JP2021501592A (ja) 2021-01-21
EP3704274B1 (en) 2024-04-17
ES2987603T3 (es) 2024-11-15
CN111511930B (zh) 2024-11-22
AU2018361833B2 (en) 2021-04-22
KR20200081380A (ko) 2020-07-07
AU2018361833A1 (en) 2020-04-30
EP3704274A2 (en) 2020-09-09
JP2023082157A (ja) 2023-06-13
PL3704274T3 (pl) 2024-07-08
SG11202003233YA (en) 2020-05-28
MY199800A (en) 2023-11-23
US11840737B2 (en) 2023-12-12
CA3078675A1 (en) 2019-05-09
NZ763540A (en) 2025-03-28
CN111511930A (zh) 2020-08-07
HUE066292T2 (hu) 2024-07-28
US20210230702A1 (en) 2021-07-29
JP7631400B2 (ja) 2025-02-18
WO2019086898A3 (en) 2019-06-13
EP3704274C0 (en) 2024-04-17

Similar Documents

Publication Publication Date Title
AU2019201577B2 (en) Cancer diagnostics using biomarkers
CN109790583B (zh) 对肺腺癌亚型分型的方法
KR102620328B1 (ko) 핵 유전자 산출량의 표적화 증강
AU2018210695B2 (en) Molecular subtyping, prognosis, and treatment of bladder cancer
KR102622309B1 (ko) 염색체 상호작용의 검출
AU2012352153B2 (en) Cancer diagnostics using non-coding transcripts
ES2374954T3 (es) Variaciones genéticas asociadas con tumores.
CN109863251B (zh) 对肺鳞状细胞癌亚型分型的方法
DK2644713T3 (en) A Method for Diagnosing Neoplasms II
KR102023584B1 (ko) 위장관췌장 신경내분비 신생물 (GEP-NENs)의 예측 방법
KR20200081380A (ko) 유전적 조절
US20190300967A1 (en) Compositions and methods for predicting response and resistance to ctla4 blockade in melanoma using a gene expression signature
KR20100017865A (ko) 유방암의 위험도 평가, 진단, 예후 및 치료용 마커인 염색체 5p12 및 염색체 10q26 상의 유전적 변이
AU2018290809B2 (en) Biomarkers for the diagnosis and treatment of fibrotic lung disease
KR20140044341A (ko) 암에 대한 분자적 진단 검사
CN101641451A (zh) chr8q24.21上的癌症易感性变体
CN116867908A (zh) 端粒的物理表征
CA2666057C (en) Genetic variations associated with tumors
KR102115948B1 (ko) 대사증후군의 위험인자 예측용 단일염기다형성 및 이의 용도
KR102901797B1 (ko) 염색체 바이오마커
CN113981071B (zh) Csf1r相关基因突变作为诊断cvm的标志物及其应用
GB2424886A (en) Polynucleotide primers against epidermal growth factor receptor and method of detecting gene mutations
CN113355332B (zh) Heg1基因突变体及其应用
KR102480128B1 (ko) 면역력 강화 소 African Humped Cattle (AFH) 품종 특이적 단일염기다형성 및 그의 용도
KR102039529B1 (ko) 대사증후군의 위험인자 예측용 단일염기다형성 및 이의 용도

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

D22 Grant of ip right intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D22-EXM-PE0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

F11 Ip right granted following substantive examination

Free format text: ST27 STATUS EVENT CODE: A-2-4-F10-F11-EXM-PR0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

U12 Designation fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U12-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

Q13 Ip right document published

Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE)